Last week was a very good one for global stocks. The MSCI World index was up around 4% over the week, tracking Wall Street with major U.S. indexes on course to snap a two-month losing streak in October. Markets will probably be seeking to the U.S. Federal Reserve meeting this week for signals that the central bank could pause its rate hikes within the near future. Among the many MSCI World stocks, 23 had weekly gains of greater than 15%, with seven surging greater than 20%, as of the close on Oct. 28. Listed below are eight of the stocks which analysts say have significant upside ahead: In U.S. names, just a few health care and pharmaceutical stocks made the list, including Moderna , Centene , and Teladoc Health. Teladoc spiked 23% last week, but only 15% of analysts covering the stock give it a buy rating. Analysts say the stock has 13% upside on average, in response to FactSet. Moderna, however, has 40% upside on average, in response to analysts covering the stock. Over 60% of analysts covering Centene give it a buy rating, and it has 18% average upside, in response to FactSet data. It jumped 16% last week week. Japanese electronics firm Ibiden surged over 20% last week, and analysts give it 23% upside on average. Greater than 90% of analysts covering the stock give it a buy rating. Last week, the firm increased its earnings-per-share guidance for the present fiscal yr, from 301 Japanese yen ($2.03) to 344 yen, in response to FactSet. Shares of U.S. energy tech company Enphase Energy were up 21% last week , though analysts expect it to rise just 3% from here. The corporate beat profit and sales expectations when it reported third-quarter earnings last week, and earlier this month, Goldman Sachs reiterated Enphase as a buying opportunity, saying “continued robust demand” within the U.S. and Europe will help the stock outperform. One other global stock with big gains was Australian gold miner Evolution Mining , which jumped 15%. Analysts covering it give it a median upside of nearly 30%. Gold prices have mostly tumbled this yr, but they jumped last week momentarily because the U.S. dollar fell. — CNBC’s Sarah Min contributed to this report.